Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study aims at evaluating the therapeutic potential of omalizumab in atopic dermatitis,
and to work out biomarkers predictive of treatment response.